• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Report: CRO participation in clinical trial design projected to increase 206% by 2020

Report: CRO participation in clinical trial design projected to increase 206% by 2020

April 15, 2016
CenterWatch Staff

Pharmaceutical and medical device teams plan to increasingly involve CROs in their clinical trial planning processes. The largest projected change is the level of vendor involvement in trial design activities, according to a recent report issued by pharmaceutical intelligence provider Cutting Edge Information.

Surveyed companies report that they currently share strategic planning duties with vendors at 17% of organizations. By 2020, the number of teams planning to share these trial design responsibilities with CROs is expected to increase to 52%.

"Projected changes to sponsor-CRO working relationships owe largely to shifts within large and mid-sized pharma companies," said Sarah Ray, senior analyst at Cutting Edge Information. "In 2014, no surveyed Top 10 or Top 50 team reported sharing trial design responsibilities with CROs or other third parties. This is drastically changing, however, as half of these surveyed teams plan to involve vendors in the clinical trial design process within the next three to five years."

Changes to other surveyed team types are more varied. Like surveyed large pharmaceutical organizations, device teams also report plans to increase vendor involvement in their clinical trial design activities. In 2014, all surveyed device teams retained trial planning responsibilities exclusively in-house. However, an estimated quarter of surveyed device teams plan to share trial design duties with CROs in the future.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing